CUTANEOUS ANGIOSARCOMA
Clinical trials for CUTANEOUS ANGIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS ANGIOSARCOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS ANGIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for rare, aggressive skin cancer
Disease control OngoingThis study tests a treatment plan for people with a rare and aggressive skin cancer called cutaneous angiosarcoma. Participants first receive a chemotherapy drug (paclitaxel) alone, then the same drug combined with radiation therapy, followed by surgery to remove the cancer. The …
Matched conditions: CUTANEOUS ANGIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 06:25 UTC
-
New drug combo shows promise against rare sarcomas
Disease control OngoingThis study tests whether combining T-VEC (a virus that attacks cancer cells) with pembrolizumab (an immunotherapy) can shrink tumors in people with advanced sarcoma that cannot be removed by surgery. About 41 adults with certain sarcoma types will receive both drugs. The main goa…
Matched conditions: CUTANEOUS ANGIOSARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:18 UTC